1. A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer. (December 2017) Authors: Tu, Hai-Yan; Ke, E-E; Yang, Jin-Ji; Sun, Yue-Li; Yan, Hong-Hong; Zheng, Ming-Ying; Bai, Xiao-Yan; Wang, Zhen; Su, Jian; Chen, Zhi-Hong; Zhang, Xu-Chao; Dong, Zhong-Yi; Wu, Si-Pei; Jiang, Ben-Yuan; Chen, Hua-Jun; Wang, Bin-Chao; Xu, Chong-Rui; Zhou, Qing; Mei, Ping; Luo, Dong-Lan Journal: Lung cancer Issue: Volume 114(2017) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases. (May 2019) Authors: Yin, Kai; Li, Yang-Si; Zheng, Mei-Mei; Jiang, Ben-Yuan; Li, Wen-Feng; Yang, Jin-Ji; Tu, Hai-Yan; Zhou, Qing; Zhong, Wen-Zhao; Yang, Xue-Ning; Chen, Hua-Jun; Yan, Hong-Hong; Li, Lin-Lin; Wu, Yi-Long; Zhang, Xu-Chao Journal: Lung cancer Issue: Volume 131(2019) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical outcomes of non–small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments. (June 2021) Authors: Zheng, Mei-Mei; Tu, Hai-Yan; Yang, Jin-Ji; Zhang, Xu-Chao; Zhou, Qing; Xu, Chong-Rui; Jiang, Ben-Yuan; Yang, Xue-Ning; Yang, Xiao-Rong; Deng, Jia-Yi; Yang, Ming-Yi; Xu, Bing-Fei; Chen, Xiu-Mei; Li, Yang-Si; Wu, Yi-Long Journal: European journal of cancer Issue: Volume 150(2021) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer. (November 2018) Authors: Liu, Si-yang; Dong, Zhong-yi; Wu, Si-pei; Xie, Zhi; Yan, Li-xu; Li, Yu-Fa; Yan, Hong-hong; Su, Jian; Yang, Jin-Ji; Zhou, Qing; Zhong, Wen-Zhao; Tu, Hai-Yan; Yang, Xue-Ning; Zhang, Xu-Chao; Wu, Yi-Long Journal: Lung cancer Issue: Volume 125(2018) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions. (September 2021) Authors: Mondaca, Sebastian; Lebow, Emily S.; Namakydoust, Azadeh; Razavi, Pedram; Reis-Filho, Jorge S.; Shen, Ronglai; Offin, Michael; Tu, Hai-Yan; Murciano-Goroff, Yonina; Xu, Chongrui; Makhnin, Alex; Martinez, Andres; Pavlakis, Nick; Clarke, Stephen; Itchins, Malinda; Lee, Adrian; Rimner, Andreas; Gome... Journal: Lung cancer Issue: Volume 159(2021) Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66–73]. (December 2021) Authors: Mondaca, Sebastian; Lebow, Emily S.; Namakydoust, Azadeh; Razavi, Pedram; Reis-Filho, Jorge S.; Shen, Ronglai; Offin, Michael; Tu, Hai-Yan; Murciano-Goroff, Yonina; Xu, Chongrui; Makhnin, Alex; Martinez, Andres; Pavlakis, Nick; Clarke, Stephen; Itchins, Malinda; Lee, Adrian; Rimner, Andreas; Gome... Journal: Lung cancer Issue: Volume 162(2021) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer. (2nd November 2017) Authors: Dong, Zhong-Yi; Zhang, Jia-Tao; Liu, Si-Yang; Su, Jian; Zhang, Chao; Xie, Zhi; Zhou, Qing; Tu, Hai-Yan; Xu, Chong-Rui; Yan, Li-Xu; Li, Yu-Fa; Zhong, Wen-Zhao; Wu, Yi-Long Journal: Oncoimmunology Issue: Volume 6:Number 11(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Integrated histological and molecular analyses of rebiopsy samples at osimertinib progression improve post-progression survivals: A single-center retrospective study. (December 2020) Authors: Cheng, Jiang-Tao; Yao, Yi-Hui; Gao, Yu-Er; Zhang, Shi-Ling; Chen, Hua-Jun; Wang, Zhen; Yan, Hong-Hong; Zhou, Qing; Tu, Hai-Yan; Zhang, Xu-Chao; Su, Jian; Xie, Zhi; Lizaso, Analyn; Chen, Shu-Yin; Lin, Xuan; Xiang, Jian-xing; Wu, Yi-Long; Yang, Jin-Ji Journal: Lung cancer Issue: Volume 150(2020) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Integrative Analyses of Lung Squamous Cell Carcinoma in Ten Chinese Patients with Transcriptome Sequencing. Issue 10 (20th October 2015) Authors: Yang, Lu-Lu; Zhang, Xu-Chao; Chuai, Shao-Kun; Chen, Zhi-Hong; Xie, Zhi; Guo, Wei-Bang; Chen, Shi-Liang; Lei, Yuan-Yuan; Guo, Long-Hua; Gou, LanYing; Sun, Hui-Wen; Zhang, Qi; Yang, Jin-Ji; Tu, Hai-Yan; Su, Jian; Wu, Yi-Long Journal: Journal of genetics and genomics Issue: Volume 42:Issue 10(2015:Oct.) Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer: 2-year follow-up from a randomized, open-label, phase 3 study (CheckMate 078). (February 2021) Authors: Lu, Shun; Wang, Jie; Cheng, Ying; Mok, Tony; Chang, Jianhua; Zhang, Li; Feng, Jifeng; Tu, Hai-Yan; Wu, Lin; Zhang, Yiping; Luft, Alexander; Zhou, Jian-ying; Ma, Zhiyong; Lu, You; Hu, Chengping; Shi, Yuankai; Ying, Kejing; Zhong, Hua; Poddubskaya, Elena; Soo, Ross A Journal: Lung cancer Issue: Volume 152(2021) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗